Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-25-001357
Filing Date
2025-02-13
Accepted
2025-02-13 18:24:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5098
  Complete submission text file 0001085146-25-001357.txt   6781
Mailing Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105
Business Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105 6263049222
PRIMECAP MANAGEMENT CO/CA/ (Filed by) CIK: 0000763212 (see all company filings)

EIN.: 953868081
Type: SCHEDULE 13G/A

Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Subject) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88653 | Film No.: 25622196
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)